LLY vs TMO
By Alex · Tickerpine
Eli Lilly and Company vs Thermo Fisher Scientific Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | TMO |
|---|---|---|
| Price | $1,233.66 | $628.15 |
| Market cap | $1.10T | $232.26B |
| P/E ratio | 41.8 | 33.8 |
| ROE | 102.29% | 13.51% |
| Profit margin | 33.53% | 15.04% |
| Revenue growth | 47.70% | 10.50% |
| Dividend yield | 0.55% | 0.30% |
| Beta | 0.51 | 0.85 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs TMO in plain English
- LLY is the bigger company — about 4.7× the market cap of TMO.
- TMO is cheaper on earnings (P/E 33.8 vs 41.8).
- LLY earns a higher return on equity (102% vs 14%).
- LLY is growing revenue faster (48% vs 10%).
- LLY has the higher dividend yield (0.55% vs 0.30%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.